Quantcast

Latest diabetes mellitus Stories

2014-10-29 23:02:34

Mount Sinai Experts Offer Tips for Better Control of the Disease New York, NY (PRWEB) October 29, 2014 Diabetes is the seventh leading cause of death in the United States. Today, 29.1 million people in the United States have been diagnosed with diabetes, according to the Centers for Disease Control and Prevention (CDC). November is Diabetes Awareness Month and Mount Sinai experts are sharing tips on prevention and detection. Experts Available for Interview: Ronald Tamler, MD, PhD,...

2014-10-29 08:33:30

NovoFine® Plus is the shortest and thinnest pen needle in the Novo Nordisk family of needles designed for diabetes pens PLAINSBORO, N.J., Oct. 29, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its shortest and thinnest pen needle, NovoFine(®) Plus, in the United States. NovoFine(®) Plus is a universal needle that works with all currently available insulin and some GLP-1 receptor agonist pens. The Food and Drug...

2014-10-23 23:05:09

Prediabetes Treatment Company Teams Up with the American Diabetes Association to Help Stop Diabetes in the Workplace Austin, Texas (PRWEB) October 23, 2014 PreDiabetes Centers, a national provider of prediabetes testing and treatment, will help host a diabetes prevention presentation at Austin Community College, Riverside Campus, on Thursday, October 30 to promote diabetes screening, as part of its collaboration with the American Diabetes Association in the Stop Diabetes @ Work...

2014-10-23 20:29:36

PASADENA, Calif., Oct. 23, 2014 /PRNewswire/ -- The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes. http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO The study included data from more than 2 million children and adolescents living in diverse geographic regions of the United States. Within this population,...

2014-10-23 20:29:30

OAKLAND, Calif., Oct. 23, 2014 /PRNewswire/ -- Women who developed gestational diabetes and were overweight before pregnancy were at a higher risk of having daughters who were obese later in childhood, according to new research published today in Diabetes Care. http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO Based on long-term research that included a multi-ethnic cohort of 421 girls and their mothers (all members of Kaiser Permanente Northern California), the study is...

2014-10-23 12:29:18

Certification demonstrates Novo Nordisk's commitment to improving diabetes care PLAINSBORO, N.J., Oct. 23, 2014 /PRNewswire/ -- Novo Nordisk, a global leader in diabetes care, was honored with The National Committee for Quality Assurance (NCQA)'s Disease Management Certification in Program Design for its Diabetes Education Program (DEP) this month. The 2-year certification validates the DEP as a program providing quality educational support to both health care providers and patients...

2014-10-23 08:35:46

New Foods for Optimizing Diabetes Control Also Offer Healthier Options for People Seeking a Sweet Treat BOULDER, Colo., Oct. 23, 2014 /PRNewswire/ -- With National Diabetes Month just around the corner, LEVEL Life(TM), a modern diabetes management company focused on empowering people with the right tools to help manage their diabetes effectively, today announced the introduction of a new line of indulgent snacks, including Peanut Butter Cups and Peanut Turtle Bars that are formulated...

2014-10-22 08:32:25

-- Relamorelin is a Novel Peptide Ghrelin Agonist for Diabetic Gastroparesis -- DUBLIN and BOSTON, Oct. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced that Actavis has been granted an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Health, Inc., which is developing relamorelin (RM-131), a peptide ghrelin agonist, for the treatment of diabetic...

2014-10-22 08:32:22

Demonstrates Proof-of-Concept for ORMD-0801 Oral Insulin to Reduce Exogenous Insulin Requirements JERUSALEM, October 22, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today reported positive top-line clinical results from its Phase IIa clinical trial of ORMD-0801, the company's proprietary oral insulin capsules, to treat type 1...

2014-10-22 08:32:13

Company launches The Diabetes Download, a new YouTube channel brought to you by Cornerstones4Care®, to help people living with diabetes incorporate better disease management into their lives. PLAINSBORO, N.J., Oct. 22, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced a new partnership with online sensation Michael Stevens, host and creator of the popular YouTube channel Vsauce, to launch a new 6-part video series, "Breaking Down Diabetes." Stevens, well known for...


Latest diabetes mellitus Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.